A safety review of prophylaxis drugs for adolescent patients with hereditary angioedema.
Henriette FarkasZsuzsanna BallaPublished in: Expert opinion on drug safety (2023)
The currently available therapeutic products have a good safety and efficiency profile and the international guidelines recommend them as first-line treatments. The choice should be made based on the evaluation of the availability and the preference of the patient.